S23 Driada Medical
| Features | |
| Active substance | S-23 |
| Also known as | S23 SARM |
| Blood pressure | Can increase blood pressure |
| Chemical name | (2S)-3-(4-cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide |
| Dosage (medical) | Not medically approved |
| Dosage (sports) | 10-30 mg per day |
| Effects | Increases muscle mass and bone density, enhances strength |
| FORM | 50 tabs x 10 mg/tab |
| Formula | C18H13F3N2O3 |
| Half-life | 12 hours |
| Hepatotoxicity | Moderate |
| Lab Test | Detection through specific blood tests for SARMs |
| Main action | Androgen receptor activation |
| Side effects | Suppression of natural testosterone, liver toxicity, potential for increased risk of heart attack and stroke |
| Storage conditions | Store in a cool, dry place away from light |
| Substance class | Selective Androgen Receptor Modulator (SARM) |
| Trade name | Not commercially available as a legitimate pharmaceutical product |
| Use in sports | Used for performance enhancement and muscle building (not legal or safe) |
| Water Retention | Low |
| Manufacturer | Driada Medical |